Introduction
============

It is well established that allergic rhinitis and asthma frequently coexist in the same subject^[@B1]^, and the *united airway disease* model has been proposed to describe a unique disease with manifestations in different sites of the respiratory system^[@B2],[@B3]^. In addition, large studies have suggested a link between the severity and/or control of asthma and rhinitis in children and adults, particularly an increased severity of asthma in patients with associated rhinitis^[@B4]^. In the occupational setting, it has been demonstrated that a majority of the patients diagnosed with occupational asthma (OA) also suffer from occupational rhinitis (OR), particularly when high molecular weight (HMW) agents are involved^[@B5]^ and that strong interactions exist between allergic OA and OR^[@B5],[@B6]^. Nevertheless, to the best of our knowledge, no specific investigation on the relationships between allergic OA and OR severity has been performed. The aim of our study was to retrospectively assess the relationships between allergic OR and OA severity and to evaluate whether OR is a predictor for increased OA severity.

Subjects and Methods
====================

We retrospectively reviewed the clinical charts of 72 patients consecutively referred to our clinics for suspected work-related respiratory allergy, who received a diagnosis of allergic OA with or without associated allergic OR in the years 2000-2008. All patients were still exposed to the suspected causative agents when investigated. Fifty-five patients were diagnosed in Italy (Fondazione Salvatore Maugeri, Pavia), and 17 were diagnosed in Spain (Hospital La Paz Institute for Health Research, Madrid). This study conformed to the declaration of Helsinki and was approved by the Internal Review Board of the two Institutes.

All patients underwent skin prick tests (SPTs) and serum specific IgE assessment for common allergens and, when available, for occupational allergens^[@B2],[@B5],[@B6]^. Lung function and methacholine inhalation tests were performed as previously described^[@B2],[@B6]^. Patients underwent the recommended diagnostic pathway for OA and OR, including the specific inhalation challenge (SIC) with HMW or low molecular weight (LMW) agents^[@B5]-[@B7]^. Each patient signed a consent form for SIC approved by the Ethical Committee of both institutes. SICs were performed using a nebulizer or in inhalation chambers depending on the suspected agent^[@B2],[@B8],[@B9]^. Rhinitis and asthma severity were established at time of the initial evaluation according to ARIA^[@B1]^ and GINA Guidelines^[@B10]^. OA and OR were diagnosed on the basis of a suggestive clinical history and a positive bronchial and nasal response to SIC, respectively^[@B5]-[@B7]^.

Data were analyzed using the Statistical Analysis System (SAS) package for PC (Version 9.3, SAS Institute, Cary, NC, USA). Values for continuous variables are expressed as mean and standard deviation. Differences in continuous variables were tested by the two-tailed *t* test or non-parametric test (Wilcoxon\'s signed-rank test) when appropriate. Differences in proportions were tested by the χ^2^ or the Fisher exact test, when appropriate. The likelihood ratio procedure described by Colombi and Forcina^[@B11]^ was applied to test the direction of association between asthma and rhinitis. This procedure tests for independence against either positive or unrestricted association; significance levels can be tuned to reduce the risk of concluding that association is positive when the true association is in both directions. Differences were considered significant at p\<0.05. Logistic regression models were used to analyze the effect of agents (HMW/LMW), atopy, smoking status, sex, country, age ≥33 years, bronchial reactivity (PD~20~FEV~1~ \<740 mcg), severity of occupational rhinitis, and duration of symptoms before the diagnosis of OA (time elapsed between the beginning of asthma symptoms and diagnosis of OA ≥ 24 months) (predictors) on asthma severity (intermittent and mild persistent *vs.* moderate-severe persistent or intermittent *vs.* mild-moderate-severe persistent) (dependent variables). Continuous variables were transformed into categorical variables using distribution above or below the median. The results are given in terms of odds ratio with 95% confidence intervals (CI).

Results
=======

Fifty-five subjects (76%) were from Italy, and 17 (24%) were from Spain. Twenty-five (35%) subjects had been diagnosed with OA-only, 7 because of HMW and 18 because of LMW agents. Forty-seven (65%) subjects had been diagnosed with associated occupational asthma and rhinitis (OAR), due to HMW agents in 24 and LMW agents in 23 subjects. The causal agent was more frequently a HMW agent in subjects with OAR (p=0.06), particularly in Italian subjects (p\<0.005). Spanish subjects were older and a greater proportion was male compared with Italian workers (p\<0.005). No significant differences were found between OA-only and OAR subjects in age, sex, smoking habits, personnel, or family history of atopy. Duration of exposure and symptoms before diagnosis of OA and OR, basal FEV~1~, and bronchial hyper-reactivity (PD~20~FEV~1~ to methacholine) did not differ between the OA-only and OAR groups (Table [1](#T1){ref-type="table"}). The time elapsed between the beginning of asthma symptoms and diagnosis tended to be shorter in subjects with OAR than in those with OA only. No differences were found in mean FEV~1~ before and after SICs. Asthma severity (intermittent/mild persistent/moderate-severe persistent) was associated with OAR (p=0.03 by χ^2^ test). The Colombi and Forcina^[@B11]^ procedure indicates that independence may be rejected in the direction of positive association when using a choice of significance levels, which is moderately conservative against positive association. However, because the evidence in the direction of positive association is not terribly strong, an extremely conservative version of the same procedure would lead to rejection of positive association. Persistent asthma tended to be more common in subjects with OAR (p=0.07). Patients with moderate-severe persistent OR more frequently had moderate-severe persistent asthma compared with those without rhinitis or with intermittent or mild persistent OR (64% *vs.* 38%, p\<0.005) (Table [2](#T2){ref-type="table"}). Nocturnal respiratory symptoms were more frequent in subjects with moderate-severe persistent OR than in those with intermittent OR and in those with OA only (72% *vs.* 27% and 32% respectively, p\<0.01). Post-SIC FEV~1~% falls were greater in Italian than in Spanish subjects (p\<0.05). Moderate-severe persistent OR was a predictor for persistent OA (odds ratio 19.0, 95%, CI 3.5-102.3). PD~20~FEV~1~ \<740 μg, LMW agents, moderate-severe OR, age ≥33, a lapse between onset and diagnosis of OA of \>24 months, and current smoking were associated with moderate-severe persistent OA (Table [3](#T3){ref-type="table"}). After adjusting for sex, smoking habits, age, atopy, and country, moderate-severe persistent OR was associated with the presence of nocturnal respiratory symptoms (odds ratio 9.3, 95%, CI 2.5-34.6).

###### 

Characteristics of the 72 subjects with occupational asthma and rhinitis

  -------------------------------------------------------------------------------------------------------------------------
  Subjects                                                           OA (n=25)   OAR (n=47)   OA+OAR (n=72)   P value^＊^
  ------------------------------------------------------------------ ----------- ------------ --------------- -------------
  Age, years (mean ± SD)                                             34.6±12.2   34.4±12.0    34.5±12.0       NS

  Sex (male/female)                                                  12/13       28/19        40/32           NS

  Smoking (yes/no/ex)                                                7/14/4      14/21/12     21/35/16        NS

  Smoking, pack-years (mean ± SD)                                    5.8±7.8     11.2±11.1    9.7±10.4        NS

  Agents (HMW/LMW)                                                   7/18        24/23        31/41           0.06

  Atopy, n (%)                                                       15 (60)     27 (57)      42 (58)         NS

  Nocturnalsymptoms, n (%)                                           8 (33)      24 (51)      32 (45)         NS

  Asthma severity\                                                   9/3/13      8/18/21      17/21/34        0.03
  (intermittent/mild persistent/moderate-severe persistent)                                                   

  Asthma severity\                                                   9/16        8/39         17/55           0.07
  (intermittent *vs* persistent)                                                                              

  Asthma severity\                                                   12/13       26/21        38/34           NS
  (intermittent + mild persistent *vs* moderate-severe persistent)                                            

  Rhinitis severity\                                                 \-          9/13/25      \-              \-
  (intermittent/mild persistent/moderate-severe persistent)                                                   

  Country (It/Es)                                                    20/5        35/12        55/17           NS

  Latency OA, months (mean ± SD)                                     101±106     103±141      102±129         NS

  Latency OR, months (mean ± SD)                                     \-          97±133       \-              \-

  Lapse onset-diagnosis OA, months (mean ± SD)                       55±83       28±30        37±56           NS

  Basal FEV~1~, % predicted (mean ± SD)                              102±16      100±13       100±14          NS

  Basal PD20FEV~1~, μg (mean ± SD)                                   1309±1387   1474±1362    1417±1363       NS

  Post-SIC FEV~1~, % predicted fall (mean ± SD)                      29±8        26±6         27±7            NS
  -------------------------------------------------------------------------------------------------------------------------

###### 

Distribution of severity of occupational asthma and rhinitis

                                  Occupational rhinitis ^a^   
  ------------------------------- --------------------------- ---------
  Occupational asthma ^b^                                     
  Intermittent                    15 (32)                     2 (8)
  Mild persistent                 14 (30)                     7 (28)
  Moderate-severe peristent ^c^   18 (38)                     16 (64)

###### 

Predictors of moderate-severe persistent occupational asthma, after adjusting for sex, smoking status, atopy and country

  Predictors                             Odds ratio   95% CI
  -------------------------------------- ------------ ----------
  Moderate/severe OR                     4.1          1.1-15.3
  PD~20~FEV~1~\<740 µg                   7.7          1.2-30.0
  LMW agent                              6.4          1.5-27.6
  Age ≥33                                8.5          1.8-39.1
  Lapse onset-diagnosis OA ≥ 24 months   4.0          1.1-15.1
  Current smoker                         10.2         2.0-51.7

Discussion
==========

Rhinitis is common in adult subjects with asthma and impairs asthma control and severity as well as asthma-related quality of life^[@B4],[@B12]^. Our retrospective study also showed an association between the severity of rhinitis and asthma in the occupational setting, although this association was statistically weak (Table [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}). This may be due to the small number of subjects (25 with OA *vs.* 47 with OAR) or due to a possible different effect of occupational agent *vs*. non-occupational agents. As previously reported^[@B2],[@B5],[@B6]^, most subjects showed the coexistence of asthma and rhinitis (OAR group). In the latter, persistent asthma tended to be more common than in subjects with OA, and moderate-severe persistent OR was associated with persistent OA and nocturnal respiratory symptoms. The shorter time interval between the beginning of asthma symptoms and diagnosis in subjects with OAR suggested that the coexistence of rhinitis induces the patients to refer to a physician earlier than subjects with bronchial impairment only, possibly because of the impact of the two concomitant diseases on the quality of life.

Taken together, all these findings show, for the first time in the occupational setting, that the severity of rhinitis affects the severity of occupational asthma. These data should be considered as a further recommendation to pay more attention to rhinitis symptoms in subjects exposed to work-related allergens. Because OR is considered an early marker of an occupational respiratory allergy^[@B5]^, early detection of nasal symptoms may represent a unique opportunity to prevent OA. Moreover, the identification of nasal symptoms may allow a better management of patients with concomitant OA.
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